CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled / 60 target
Drug / intervention
Blood Flow Restriction (BFR) therapy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04519801
NCT04519801N/ACompletedOn Track (1.3/mo)Completion was 4mo ago

Blood Flow Restriction Therapy for the Post-Operative Rehabilitation of Anterior Cruciate Ligament Reconstruction With Quadriceps Tendon Autograft: A Randomized, Controlled Trial

Brooke Army Medical Center·interventional·Posted Aug 20, 2020·Updated Jun 29, 2026

In Brief

A clinical study evaluating Blood Flow Restriction (BFR) therapy and Standard REHAB for ACL Injury. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The overall objective of the proposed research is to conduct a prospective, randomized controlled trial to investigate whether the addition of BFR therapy to standard post-operative rehabilitation regimen significantly improves clinical outcomes following anterior cruciate ligament reconstruction (ACLR) standardized with respect to both surgical technique and graft selection. Patients indicated for ACLR will be screened and offered enrollment into this prospective, randomized controlled trial. MRI of bilateral thighs will be performed within 7 days of ACLR. Patients will be randomized to either REHAB or REHAB + BFR (study intervention) using a block randomization scheme. Patients will undergo repeat MRI of bilateral thighs pre-surgery, at 16 weeks, and at 56 weeks post-operatively (primary outcome measure.) Patient reported outcome (PRO) instruments will be administered pre-operatively to establish pre-operative debility related to ACL injury and subsequently after ACLR at 28 weeks, 40 weeks, and 56 weeks post-operative (secondary outcome measures).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsACL Injury
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 20, 2020
Enrollment StartSep 9, 2022
Primary CompletionFeb 13, 2026
Study CompletionMar 1, 2026
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 5.9 years ago

Arms & Interventions

REHABother

Standard post-operative rehabilitation regimen (REHAB) (Control)

Other: Standard REHAB
REHAB + BFRexperimental

Standard rehabilitation regimen with BFR therapy (REHAB + BFR) (Experimental)

Other: Blood Flow Restriction (BFR) therapyOther: Standard REHAB

Interventions

Blood Flow Restriction (BFR) therapyother

BFR therapy beginning after first MD follow up appointment after ACL reconstruction with quadriceps tendon autograft and the following functional criteria have been met: 1.) incisions healing or healed without signs of infection or dehiscence. 2.) ROM to at least 90 degree flexion. 3.) Able to perform unilateral weight bearing for 5 seconds. 4.) Pain under control and minimal knee effusion.

Standard REHABother

Standard post-operative rehabilitation regimen (REHAB) beginning after first MD follow up appointment ACL reconstruction with quadriceps tendon autograft and the following functional criteria have been met: 1.) incisions healing or healed without signs of infection or dehiscence. 2.) ROM to at least 90 degree flexion. 3.) Able to perform unilateral weight bearing for 5 seconds. 4.) Pain under control and minimal knee effusion